市场调查报告书
商品编码
1470407
空间组学市场:按技术、样本类型、产品、工作流程和最终用途 - 2024-2030 年全球预测Spatial OMICS Market by Technology (Genomics, Proteomics, Transcriptomics), Sample Type (FFPE, Fresh Frozen), Product, Workflow, End-use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年空间组学市场规模为5.2118亿美元,预计2024年将达5.8666亿美元,2030年将达到12.3748亿美元,复合年增长率为13.14%。
空间组学包含用于分析细胞、组织和生物体内生物分子空间组织的先进技术和技术。该部门服务于製药、生物技术、学术研究和诊断等各行业。癌症等复杂疾病的盛行率不断上升、次世代定序(NGS) 的进步以及政府对生命科学研究倡议的资助等因素正在扩大空间组学的应用领域。然而,与实施先进成像工具相关的高成本,以及资料标准化和互通性问题,可能会阻碍市场成长。然而,人工智慧 (AI) 和机器学习 (ML) 等蓬勃发展的技术有可能彻底改变空间组学研究中的资料分析。此外,利用云端运算技术并整合转录组学、蛋白质组学、代谢体学和基因组学的多组体学平台的市场开拓预计将为市场带来成长前景。
主要市场统计 | |
---|---|
基准年[2023] | 52118万美元 |
预测年份 [2024] | 5.8666亿美元 |
预测年份 [2030] | 1,237.48 百万美元 |
复合年增长率(%) | 13.14% |
质谱技术的普及,取得产品组织中各种分子的空间分布
消耗品包括样品製备、成像和资料分析所需的试剂、探针、抗体和缓衝液等关键组件。研究人员对耗材的偏好因样品类型、目标分子、灵敏度等级、通量需求和预算限制等因素而异。该仪器是在空间组学实验中产生各种分辨率的高品质资料的重要工具。关键设备包括显微镜、玻片扫描仪、质谱仪和次世代定序仪。质谱成像涉及直接分析来自组织切片的分子数量的空间分布,通常放置在导电载玻片上以使样品表面导电。软体对于透过影像分割工具分析和解释空间组学资料至关重要。使用者偏好取决于硬体相容性、易用性、与现有资料分析流程和 LIMS 系统的整合、可扩展性和自订选项等因素。
最终用途学术研究机构和转化研究机构如何使用空间组学技术研究细胞机制的案例
学术和转化研究机构正在采用空间组学技术来增强其研究能力。空间组学工具使学术和转化研究机构能够加深对细胞机制、疾病进展和生物标记识别的理解,并为新型治疗性介入的研究和开发做出贡献。製药和生物技术公司使用空间组学技术来确定目标的优先顺序、识别生物标记并简化药物发现过程。
区域洞察
由于美国和加拿大等地区对研发的大量投资,以及生技公司、研究机构和学术机构的支持,全球太空组学市场正在新兴市场显着成长。在欧洲,瑞典和德国等国家透过「地平线 2020」等欧盟资助的计划在太空组学技术投资方面处于主导。欧洲生物资讯实验室 (EMBL) 和 Wellcome Sanger研究所等研究机构为此领域的发展做出了重大贡献。在中东地区,人们越来越关注精准医学和基因组研究,扩大了在临床决策中使用空间 OMIC 技术的机会。此外,鑑于生物技术领域的成长以及中国和印度等主要经济体政府对科学研究的资助增加,亚太地区的 OMICS 在这一领域具有巨大的成长潜力。透过生物技术部 (DBT) 的大力投资,Spatial OMIC 技术正在印度逐渐被采用,这可能为对此类创新应用感兴趣的研究人员和行业参与企业之间的合作铺平道路。
FPNV定位矩阵
FPNV定位矩阵对于评估Spatial OMICS市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 Spatial OMICS 市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动和突破性产品开发的智力见解。
1. 空间组学市场的市场规模与预测是多少?
2.在空间组学市场预测期内,我们应该考虑投资哪些产品与应用?
3. 空间组学市场的技术趋势和法规结构是什么?
4.空间组学市场主要厂商的市场占有率是多少?
5. 进入空间组学市场的适当形式和策略手段是什么?
[188 Pages Report] The Spatial OMICS Market size was estimated at USD 521.18 million in 2023 and expected to reach USD 586.66 million in 2024, at a CAGR 13.14% to reach USD 1,237.48 million by 2030.
Spatial omics encompasses advanced techniques and technologies for analyzing the spatial organization of biological molecules within cells, tissues, and organisms. This sector serves various industries, including pharmaceuticals, biotechnology, academic research, and diagnostics. Factors such as the rising prevalence of complex diseases like cancer, along with the advancements in next-generation sequencing (NGS) and government funding for life science research initiatives, have increased the application areas of spatial omics. However, high costs associated with implementing advanced imaging tools, along with data standardization and interoperability concerns, may impede market growth. However, booming technologies such as artificial intelligence (AI) and machine learning (ML) hold the potential to revolutionize data analysis in spatial omics studies. Furthermore, the development of integrated multi-omics platforms that combine transcriptomics, proteomics, metabolomics, and genomics, leveraging cloud computing technology, is expected to provide growth prospects for the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 521.18 million |
Estimated Year [2024] | USD 586.66 million |
Forecast Year [2030] | USD 1,237.48 million |
CAGR (%) | 13.14% |
Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue
Consumables include vital components such as reagents, probes, antibodies, and buffers for sample preparation, imaging, and data analysis. Researchers' preferences for consumables depend on factors such as sample type, target molecule, sensitivity levels, throughput needs, and budget constraints. Instruments are essential tools that generate high-quality data at various resolutions in spatial OMICS experiments. Key instruments encompass microscopes, slide scanners, mass spectrometry instruments, and next-generation sequencing platforms. Mass spectrometry imaging analyzes the spatial distribution of the number of molecules directly from tissue sections, usually placed on conductive glass slides to create conductivity on the sample surface. Software is vital for analyzing and interpreting spatial OMICS data through image segmentation tools. User preferences are determined by factors such as hardware compatibility, ease of use, integration with existing data analysis pipelines or LIMS systems, scalability, and customization options.
End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies
Academic & translational research institutes adopt spatial OMICS technologies to advance their research capabilities. Spatial OMICS tools allow academic & translational research institutes to have a better understanding of cellular mechanisms, disease progression, biomarker identification, and contribute towards the development of novel therapeutic interventions. Pharmaceutical & biotechnology companies are utilizing the Spatial OMICS technologies for prioritize target validation, biomarker identification, and streamlining drug discovery processes.
Regional Insights
The global spatial OMICS market is experiencing significant growth across the Americas region owing to significant investment led in research and development across regions such as the United States & Canada, supported by the presence of biotechnology & research companies along with academic institutions. In Europe, countries like Sweden and Germany lead investments in spatial OMICS technologies through EU-funded projects like Horizon 2020. Research institutes such as The European Bioinformatics Institute(EMBL) and Wellcome Sanger Institute contribute significantly to advancing this field. Increasing focus on precision medicine and genomic research in the Middle East region opens up opportunities for adopting spatial OMIC technologies in clinical decision-making. Moreover, the Asia Pacific region holds the growth potential for the spatial OMICS, considering the growing biotechnology sectors and increased government funding for scientific research across major economies such as China & India. India is gradually adopting spatial OMIC technology through substantial investments by its Department of Biotechnology (DBT), potentially paving the way for partnerships between researchers and industry players interested in these innovative applications.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Spatial OMICS Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spatial OMICS Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Spatial OMICS Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Brooks Automation, Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC by Cantata Bio, LLC, Hologic, Inc., IonPath, Inc., Lunaphore Technologies S.A., Molecular Machines & Industries GmbH, NanoString Technologies, Inc., PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve BioSciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics Inc, Standard BioTools Inc., Ultivue, Inc., Veranome Biosystems, LLC by Applied Materials, Inc., and Vizgen, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Spatial OMICS Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spatial OMICS Market?
3. What are the technology trends and regulatory frameworks in the Spatial OMICS Market?
4. What is the market share of the leading vendors in the Spatial OMICS Market?
5. Which modes and strategic moves are suitable for entering the Spatial OMICS Market?